Stay updated on Pediatric Solid Tumors B7-H3 Clinical Trial
Sign up to get notified when there's something new on the Pediatric Solid Tumors B7-H3 Clinical Trial page.

Latest updates to the Pediatric Solid Tumors B7-H3 Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov page footer displays an updated site revision, from v3.8.0 to v3.8.1.SummaryDifference0.2%

- Check7 days agoChange DetectedThe page now displays the study record for a Phase 1 trial of enoblituzumab in children and young adults with B7-H3-expressing solid tumors, including its study details and participation information.SummaryDifference49%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe site footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check28 days agoChange DetectedA banner announces NIH website updates and says some content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference1%

- Check35 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to Pediatric Solid Tumors B7-H3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Solid Tumors B7-H3 Clinical Trial page.